20.07.2015 Views

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

VAAM-Jahrestagung 2012 18.–21. März in Tübingen

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

151bodies. Hence, we started to develop a novel bacterial expression systemfor the synthesis of membrane prote<strong>in</strong>s that is based on the phototsyntheticbacterium Rhodobacter capsulatus. Due to its unique physiologicalproperties the photosynthetic bacterium R. capsulatus is particularly suitedfor the high-level expression of membrane bound enzymes <strong>in</strong> an activeform: Phototrophic growth conditions <strong>in</strong>duce an <strong>in</strong>tracellulardifferentiation of the <strong>in</strong>ner membrane, lead<strong>in</strong>g to the formation ofmembrane vesicles <strong>in</strong> R. capsulatus. The membrane vesicles <strong>in</strong> turnprovide an <strong>in</strong>tr<strong>in</strong>sically high prote<strong>in</strong> fold<strong>in</strong>g and <strong>in</strong>corporation capacity.In order to evaluate the optimal growth conditions for heterologousmembrane prote<strong>in</strong> expression we started to express two differentmembrane prote<strong>in</strong>s, the bacteriorhodops<strong>in</strong> from Halobacterium sal<strong>in</strong>ariumas well as the squalene epoxidase from Stigmatella aurantiaca, underphototrophic, non-phototrophic as well as shifted conditions. Furthermore,<strong>in</strong>tegration of the heterologous membrane prote<strong>in</strong>s <strong>in</strong>to the photosyntheticmembrane vesicles was confirmed by prote<strong>in</strong> localization studies. Thenovel R. capsulatus expression system will now be used to identify novelmembrane bound monooxgenases from metagenomic libraries.OTP061Dehalococcoides sp. stra<strong>in</strong> CBDB1 reductively dehalogenatesbromobenzenes to benzene <strong>in</strong> a respiratory processM. Cooper* 1 , A. Wagner 2 , S. Ferdi 2 , J. Seifert 1 , L. Adrian 11 Helmholtz Centre for Environmental Research, Isotope Biogeochemistry,Leipzig, Germany2 Technische Universität Berl<strong>in</strong>, Angewandte Biochemie, Berl<strong>in</strong>, GermanyBrom<strong>in</strong>ated aromatics have broad applications <strong>in</strong> <strong>in</strong>dustry as flameretardants and fumigants or as <strong>in</strong>termediates dur<strong>in</strong>g the synthesis of dyes,agrochemicals, pharmaceuticals and herbicides. By now, many brom<strong>in</strong>atedcompounds are widespread contam<strong>in</strong>ants <strong>in</strong> the environment and areregarded as potentially harmful to humans and the environment. However,brom<strong>in</strong>ated aromatics are also released naturally, particularly <strong>in</strong> mar<strong>in</strong>eecosystems by algae, polychaets, sponges and molluscs. The completeremoval of all halogen substituents is a crucial step <strong>in</strong> the degradationprocess and for further m<strong>in</strong>eralization of halogenated compounds. Abacterial group which is known for its ability to reductively dehalogenate abroad range of toxic chlor<strong>in</strong>ated compounds such as chloroethenes,chlorobenzenes, chlorobiphenyls and diox<strong>in</strong>s is the genus of theDehalococcoides.In this study we <strong>in</strong>vestigated whether the pure Dehalococcoides sp. stra<strong>in</strong>CBDB1 is able to dehalogenate brom<strong>in</strong>ated benzenes, which were chosenas ‘model’ molecules for other more complex brom<strong>in</strong>ated compounds fromnatural or anthropogenic sources. Cultivation of stra<strong>in</strong> CBDB1 with 1,2,4-tribromobenzene, three different dibromobenzene congeners ormonobromobenzene revealed that all tested bromobenzenes werereductively dehalogenated to benzene <strong>in</strong> a respiratory process. Growthyields of 1.8 x 10 14 to 2.8 x 10 14 cells per mol of bromide released wereobta<strong>in</strong>ed. Additionally a newly designed methylviologen based enzymeactivity test was established to assess enzyme activity towardsbromobenzenes. Furthermore mass spectrometric analyses of reductivedehalogenases were carried out to ga<strong>in</strong> deeper <strong>in</strong>sight <strong>in</strong>to expressionpatterns of reductive dehalogenases after cultivation with differentbromobenzenes. Our f<strong>in</strong>d<strong>in</strong>gs <strong>in</strong>dicate that the same enzymes are <strong>in</strong>volveddur<strong>in</strong>g bromobenzene reduction as dur<strong>in</strong>g chlorobenzene reduction, andsuggest that Dehalococcoides sp. stra<strong>in</strong> CBDB1 can be used forremediation of brom<strong>in</strong>ated aromatic contam<strong>in</strong>ants.OTP062BlueTox: A novel genetically encoded photosensitizerS. Endres* 1 , J. Walter 2 , J. Potzkei 1 , M. W<strong>in</strong>gen 1 , A. Heck 1 , K.-E. Jaeger 3 ,T. Drepper 11 He<strong>in</strong>rich-He<strong>in</strong>e-University, Institute of Molecular Enzyme Technology, WGDrepper, Düsseldorf, Germany2 He<strong>in</strong>rich-He<strong>in</strong>e-University, Department of Neurology, Düsseldorf, Germany3 He<strong>in</strong>rich-He<strong>in</strong>e-University, Institute of Molecular Enzyme Technology,Düsseldorf, GermanyFluorescent active dyes and prote<strong>in</strong>s like the green fluorescent prote<strong>in</strong>(GFP), isolated from the jellyfish Aequorea victoria and members of theGFP-like prote<strong>in</strong> family generates reactive oxygen species (ROS) as abyproduct of its fluorescence activity (1) . Thereby, the amount of generatedROS is strongly dependent on the prote<strong>in</strong>s structure (2,3) . One example for ahigh-level ROS-produc<strong>in</strong>g fluorescent prote<strong>in</strong> is KillerRed, a derivate ofthe non-fluorescent chromoprote<strong>in</strong> anm2CP isolated from Anthemedusaesp. (4) . This photosensitizer enables the light-mediated directed <strong>in</strong>activationof targeted cell-structures and/or whole cells by application of thechromophore-assisted-light-<strong>in</strong>activation (CALI-) technique(5) . As analternative to this red fluorescent photosensitizer we developed, on basis ofa FMN-based-fluorescent-prote<strong>in</strong> (FbFP) (6) , the novel photosensitizerBlueTox. BlueTox harbors a LOV-doma<strong>in</strong> (light, oxygen, voltage) thatb<strong>in</strong>ds flav<strong>in</strong>mononucleotide (FMN) as fluorophore and shows thecharacteristic excitation and emission maxima at 450nm ex /495nm em , respectively.We demonstrated the blue-light <strong>in</strong>duced, ROS-mediated photosensitiz<strong>in</strong>geffect of BlueTox by heterologous expression of the photosensitizer <strong>in</strong>Escherichia coli and subsequent time-resolved irradiation studies. Theresults of our <strong>in</strong> vivo analyses revealed a significant correlation betweendecrease of the amount of liv<strong>in</strong>g cells and irradiation time. Therefore,BlueTox is a powerful tool for light-mediated <strong>in</strong>activation of bacteria withhigh spatio-temporal resolution.1Jiménez-Banzo, A., S. Nonell, et al. (2008). "S<strong>in</strong>glet Oxygen Photosensitization by EGFP and itsChromophore HBDI." Biophysical journal 94 (1): 168-172.2Pletnev, S., N. G. Gurskaya, et al. (2009). "Structural basis for phototoxicity of the genetically encodedphotosensitizer KillerRed." The Journal of biological chemistry 284 (46): 32028-32039.3Carpentier, P., S. Violot, et al. (2009). "Structural basis for the phototoxicity of the fluorescent prote<strong>in</strong>KillerRed. "FEBS letters 583 (17): 2839-2842.4Bul<strong>in</strong>a, M. E., D. M. Chudakov, et al. (2006). "A genetically encoded photosensitizer." Naturebiotechnology 24 (1): 95-99.5Bul<strong>in</strong>a, M. E., K. A. Lukyanov, et al. (2006). "Chromophore-assisted light <strong>in</strong>activation (CALI) us<strong>in</strong>g thephototoxic fluorescent prote<strong>in</strong> KillerRed. "Nature protocols 1 (2): 947-953.6Drepper, T., T. Eggert, et al. (2007). "Reporter prote<strong>in</strong>s for <strong>in</strong> vivo fluorescence without oxygen." Naturebiotechnology 25 (4): 443-445.OTP063Production of the liposomase <strong>in</strong> Clostridium sporogenes for thetherapeutic use <strong>in</strong> tumor therapyK. Riegel* 1 , D. Meisohle 2 , P. Dürre 11 Universität Ulm, Institut für Mikrobiologie und Biotechnologie, Ulm, Germany2 Universität Ulm, Institut für Mediz<strong>in</strong>ische Mikrobiologie and Hygiene, Ulm,GermanySolid tumors and their environment possess certa<strong>in</strong> features that are unique<strong>in</strong> the human body. The most strik<strong>in</strong>g one is oxygen deprivation. Theseregions offer obligate anaerobic bacteria, such as clostridia, optimalconditions for growth. However, the colonization of the tumors alone isnot sufficient for a complete tumor regression (Ryan et al., 2006). Bygenetic modifications, these bacteria can function as vectors deliver<strong>in</strong>gtherapeutic prote<strong>in</strong>s or prodrug-convert<strong>in</strong>g enzymes to their targetsresult<strong>in</strong>g <strong>in</strong> a direct effect on the rema<strong>in</strong><strong>in</strong>g tumor tissue.In this project, the liposomase is used for this purpose. The liposomase is aprote<strong>in</strong> orig<strong>in</strong>ally isolated from Clostridium novyi that can destroyliposomes (Cheong et al., 2006). Liposomes are membranous vesicleswhich can function as carrier for anticancer drugs such as doxorubic<strong>in</strong>, asthese vesicles specifically accumulate <strong>in</strong> tumor tissues. However, the drugrelease from the liposomes is very slow due to their chemical and physicalstability (Gabizon et al., 2006). Therefore, a genetically eng<strong>in</strong>eered stra<strong>in</strong>of Clostridium sporogenes produc<strong>in</strong>g this enzyme should greatly enhancedrug delivery from liposomes. C. sporogenes is a proteolytic and sporeform<strong>in</strong>gorganism that proved to be an excellent colonizer of hypoxictumor tissue (Brown and Liu, 2004). For the expression of the liposomasegene <strong>in</strong> this organism a prote<strong>in</strong> expression system based on the T7 systemwas constructed. The result<strong>in</strong>g expression mutant of C. sporogenes shouldproduce and secrete the liposomase <strong>in</strong> the surround<strong>in</strong>g medium <strong>in</strong> asufficient concentration provid<strong>in</strong>g a more effective strategy <strong>in</strong> the fightaga<strong>in</strong>st cancer.Brown, J.M., & Liu, S.C., 2004. Use of anaerobic bacteria for cancer therapy. In: Nakano, M.M., & Zuber P.Strict and facultative anaerobes - medical and environmental aspects. Horizon Bioscience, Wymondham,England, 211-220.Cheong I., Huang X., Bettegowda C., Diaz L.A. Jr., K<strong>in</strong>zler K.W., Zhou S. and Vogelste<strong>in</strong> B., 2006. Abacterial prote<strong>in</strong> enhances the release and efficacy of liposomal cancer drugs. Science, 314, 1308-1311.Gabizon A.A., Shmeeda H. and Zakipsky S., 2006. Pros and Cons of the liposome platform <strong>in</strong> cancer drugtarget<strong>in</strong>g. Journal of Liposome Research, 16, 175-183.Ryan, R.M., Green, J., & Lewis, C.E., 2006. Use of bacteria <strong>in</strong> anti-cancer therapies. BioEssays, 28, 84-94.OTP064ClubSub-P: cluster-based subcellular localization predictionfor Gram-negative bacteria and archaeaN. Paramasivam*, D. L<strong>in</strong>keMPI Developmental Biology, Prote<strong>in</strong> Evolution, Tuebigen, GermanyThe subcellular localization (SCL) of prote<strong>in</strong>s provides important clues totheir function <strong>in</strong> a cell. In our efforts to predict useful vacc<strong>in</strong>e targetsaga<strong>in</strong>st Gram-negative bacteria, we noticed that misannotated start codonsfrequently lead to wrongly assigned SCLs. This and other problems <strong>in</strong>SCL prediction, such as the relatively high false-positive and falsenegativerates of some tools, can be avoided by apply<strong>in</strong>g multipleprediction tools to groups of homologous prote<strong>in</strong>s.Here we present ClubSub-P, an onl<strong>in</strong>e database that comb<strong>in</strong>es exist<strong>in</strong>gSCL prediction tools <strong>in</strong>to a consensus pipel<strong>in</strong>e from more than 600proteomes of fully sequenced microorganisms. On top of the consensusprediction at the level of s<strong>in</strong>gle sequences, the tool uses clusters ofhomologous prote<strong>in</strong>s from Gram-negative bacteria and from Archaea toelim<strong>in</strong>ate false-positive and false-negative predictions. ClubSub-P canassign the SCL of prote<strong>in</strong>s from Gram-negative bacteria and Archaea withhigh precision. The database is searchable, and can easily be expandedus<strong>in</strong>g either new bacterial genomes or new prediction tools as they becomeavailable. This will further improve the performance of the SCL prediction, aswell as the detection of misannotated start codons and other annotation errors.ClubSub-P is available onl<strong>in</strong>e athttp://toolkit.tueb<strong>in</strong>gen.mpg.de/clubsubp/Paramasivam N and L<strong>in</strong>ke D (2011) ClubSub-P: cluster-based subcellular localization predictionfor Gram-negative bacteria and archaea. Front. Microbio. 2:218. doi: 10.3389/fmicb.2011.00218BIOspektrum | Tagungsband <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!